Skip to main content
PYVAX logo

Payden Equity Income Fund Adviser Cl (PYVAX) Fund Overview

Educational signal · not a buy or sell recommendation · How to read this

$18.83 +$0.14 (+0.75%)
P/E Ratio: 6.80|

P/E 6.80 means the share price is 6.80 times one year of earnings per share. Beta 0.80: the stock has moved about 20% less than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Payden Equity Income Fund Adviser Cl (PYVAX) trades at $18.83. Sector: Financials.

Price as of · Last analyzed: Jun 14, 2026
Payden Equity Income Fund Adviser Cl (PYVAX) is a closed-end management investment company based in Los Angeles, focusing on long-term capital appreciation and current income through investments in dividend-paying equities. The fund primarily targets large-cap value stocks while maintaining a diversified portfolio that includes international equities and other income-generating instruments.

Analyst Coverage for PYVAX: PYVAX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

▶ Watch the PYVAX film Every key number, told as a short cinematic story — just press play. ~2 min

Payden Equity Income Fund Adviser Cl (PYVAX) Financial Services Profile

HeadquartersLos Angeles, US
IPO Year2011

Payden Equity Income Fund Adviser Cl (PYVAX) specializes in generating income and capital appreciation through a diversified portfolio of large-cap value stocks and income-producing assets, positioning itself as a reliable choice for income-focused investors in the asset management sector.

Data Provenance | Financial Data Quantitative Analysis Analysis: Jun 14, 2026

What Is the Investment Thesis for PYVAX?

AI-written as of Jun 14, 2026 — figures and tone reflect the data available then, not today's score.

With a profit margin of 1213.7% and a gross margin of 100%, the fund demonstrates strong operational efficiency and profitability. The fund's current dividend yield of 5.76% positions it favorably in the market, attracting income-focused investors. Key growth catalysts include the potential for capital appreciation from large-cap value stocks and the ability to tap into international markets, which could enhance returns. However, investors should remain cognizant of risks such as market volatility and interest rate fluctuations that may impact the fund's performance. Overall, the combination of a solid investment strategy and favorable financial metrics underpins the fund's potential for continued growth and income generation.

Based on FMP financials and quantitative analysis

PYVAX Key Highlights

AI-written as of Jun 14, 2026 — figures and tone reflect the data available then, not today's score.

Market capitalization of $1.31 billion highlights its significant presence in the asset management industry.

  • Profit margin of 1213.7% indicates exceptional operational efficiency.
  • Gross margin of 100.0% reflects strong profitability from its investment strategy.
  • Dividend yield of 5.76% attracts income-focused investors.
  • Beta of 0.80 suggests lower volatility compared to the broader market.

Who Are PYVAX's Competitors?

PYVAX is benchmarked below against 4 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
VIG Vanguard Dividend Appreciation ETF $236.09 +0.44% $128B —
DVY iShares Select Dividend ETF $153.05 +0.22% $22.3B —
SDY State Street SPDR S&P Dividend ETF $147.82 +0.17% $20.4B —
EICA Eagle Point Income Company Inc. $25.00 +0.04% $234M 36 5-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are PYVAX's Key Strengths?

High profit margin of 1213.7% indicates strong operational performance.

  • Diversified portfolio reduces exposure to individual asset risks.
  • Established investment strategy focused on income generation.

What Are PYVAX's Weaknesses?

Limited to large-cap value stocks may restrict growth potential.

  • Exposure to market volatility can affect fund performance.
  • Dependence on dividend-paying equities may limit total return.

What Are the Key Risks for PYVAX?

Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.

  • Market volatility may impact the fund's net asset value.
  • Interest rate fluctuations could affect the performance of dividend-paying stocks.
  • Economic downturns may lead to reduced income from portfolio holdings.

What Threats Does PYVAX Face?

  • Rising interest rates could negatively impact dividend-paying stocks.
  • Economic downturns may lead to reduced dividend payouts from holdings.
  • Intense competition in the asset management industry may pressure margins.

What Are PYVAX's Competitive Advantages?

  • Strong focus on large-cap value stocks provides stability and reliability.
  • Diversified investment strategy mitigates risks associated with market volatility.
  • High profit and gross margins indicate operational efficiency.
  • Established reputation in the asset management industry enhances trust with investors.
  • Flexibility to invest in international equities broadens growth potential.

What Does PYVAX Do?

Founded in Los Angeles, Payden Equity Income Fund Adviser Cl (PYVAX) operates as a closed-end management investment company, dedicated to providing investors with both long-term capital appreciation and a steady stream of income. The fund's investment strategy is primarily focused on well-established, large-capitalization value stocks, which are characterized by their substantial market value and propensity to deliver above-average dividend yields. In addition to its core holdings in U.S. securities, the fund has the flexibility to allocate up to 30% of its total assets to international equities, including those from developing nations, thereby enhancing its diversification and potential for income generation. The Payden Equity Income Fund also diversifies its portfolio by investing in various equity-related instruments that produce income, such as preferred shares, real estate investment trusts (REITs), and master limited partnerships (MLPs). This diversified approach not only mitigates risks associated with market volatility but also capitalizes on different income-generating opportunities across various sectors. The fund's market position is strengthened by its focus on dividend-paying equities, making it an appealing choice for investors seeking consistent income. As of now, PYVAX boasts a market capitalization of $1.31 billion, reflecting its significant presence in the asset management industry.

What Products and Services Does PYVAX Offer?

  • Manage a diversified portfolio of large-cap value stocks.
  • Focus on generating current income through dividend-paying equities.
  • Invest in preferred shares, REITs, and MLPs to enhance income generation.
  • Allocate up to 30% of assets to international equities for diversification.
  • Aim for long-term capital appreciation alongside current income.
  • Operate as a closed-end management investment company.

How Does PYVAX Make Money?

  • Generate revenue through management fees based on assets under management.
  • Earn income from dividends and interest on portfolio investments.
  • Capitalize on capital appreciation of equity holdings.
  • Diversify income sources through investments in various asset classes.
  • Leverage market opportunities to optimize portfolio performance.

What Industry Does PYVAX Operate In?

The asset management industry, particularly in the income-focused segment, has seen substantial growth as investors increasingly seek reliable income streams amid low interest rates. The market for income-generating investments is projected to expand, driven by demographic trends such as aging populations and the need for retirement income. Payden Equity Income Fund Adviser Cl (PYVAX) fits into this landscape by providing a diversified investment approach that targets both capital appreciation and current income, positioning itself competitively against peers in the asset management sector. The fund's focus on large-cap value stocks and income-producing instruments aligns well with current market demands for stability and yield.

Who Are PYVAX's Key Customers?

  • Individual investors seeking income and capital appreciation.
  • Institutional investors looking for diversified income-generating investments.
  • Retirement funds needing stable income streams.
  • Financial advisors recommending income-focused investment options.
  • Wealth management firms managing client portfolios.
Model self-rating on this text: 65% (not a measure of the evidence) Updated: Jun 14, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● Price is current
  • ● No filing on record
  • ● No analyst coverage
  • ● This is a fund, not an operating company
ROE 18%

Key Financial Metrics

Return on equity for Payden Equity Income Fund Adviser Cl stands at 18.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 17.3%, showing how much profit it generates from its asset base. A current ratio of 0.73 means current liabilities exceed short-term assets, a liquidity point worth watching.

F-Score 2/9

Financial Health

Payden Equity Income Fund Adviser Cl's Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.

PYVAX Financials

Bull Case vs Bear Case

Bull Case

  • High profit margin of 1213.7% indicates strong operational performance.
  • Diversified portfolio reduces exposure to individual asset risks.
  • Established investment strategy focused on income generation.
  • Upcoming: Continued focus on dividend-paying equities as interest rates stabilize.

Bear Case

  • Limited to large-cap value stocks may restrict growth potential.
  • Exposure to market volatility can affect fund performance.
  • Dependence on dividend-paying equities may limit total return.
  • Potential: Market volatility may impact the fund's net asset value.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · June 2026

PYVAX Latest News

No recent news available for PYVAX.

PYVAX Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for PYVAX.

Price Targets

Wall Street price target analysis for PYVAX.

PYVAX MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for PYVAX; grades run from A+ (80-100) to F (below 30).

Common Questions About PYVAX (Financials)

How does Payden Equity Income Fund Adviser Cl ensure portfolio diversification?

The fund employs a diversified investment strategy that includes a mix of large-cap value stocks, preferred shares, REITs, and MLPs.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

MoonshotScore is not published for this security.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Data is based on available information as of June 2026.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis